NEJM:发现与睾丸癌有关的自身免疫性疾病

2021-07-09 Viho MedSci原创

科学家们利用先进技术,发现了一种似乎会影响男性睾丸癌患者的自身免疫疾病。这种疾病被称为 "睾丸癌相关的副肿瘤性脑炎",会导致男性出现严重的神经系统症状。

科学家们利用先进技术,发现了一种似乎会影响男性睾丸癌患者的自身免疫疾病。这种疾病被称为 "睾丸癌相关的副肿瘤性脑炎",会导致男性出现严重的神经系统症状。他们逐渐失去对四肢、眼睛运动的控制,在某些情况下还会失去语言能力。这种疾病始于睾丸肿瘤,它似乎导致免疫系统攻击大脑。受影响的男性经常发现自己被误诊或未被诊断,适当的治疗被推迟。 发表于New England Journal of Medicine的一项研究中,科学家们通过使用 "可编程噬菌体显示 "技术的一个变体,它是一种改进的人类可编程显示系统,为筛选新抗原而设计的,可以确定了该疾病的一个高度特异和独特的生物标志物。研究人员对这种技术的改进版本同时筛选了所有人类蛋白质中的70多万个自身抗体目标。 利用这一强大的工具,加州大学旧金山分校的研究人员评估了一名37岁男子的脑脊液,该男子有睾丸癌病史,并有衰弱的神经系统症状,包括眩晕、肢体不协调和说话不清。增强的噬菌体技术确定了针对Kelch样蛋白11(KLHL11)的自身抗体,该蛋白存在于睾丸和部分大脑中。 副肿瘤性菱形脑炎患者血清抗KLHL 11抗体的发现及正交验证。 这些结果其他病人样本

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2022-01-26 ms4000002110537530

    有意思

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-30 ms7919221313595046

    nice

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-13 走,走走

    有意思

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-11 zhangph
  6. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 仁术2021

    不错学习了

    0

相关资讯

Brit J Cancer:癌症家族史与儿童和青年人睾丸癌风险

该研究发现患有TC、癌、间皮瘤、肉瘤、恶性黑素瘤和恶性神经上皮肿瘤家族史的儿童和年轻人患TC的风险增加。遗传性癌症综合征可能是本研究报道的一些关联的基础。

Sci Rep:睾丸癌患者异种移植模型的建立和表征-用于新治疗策略的临床前评估

睾丸癌(TC)是年轻男性最常见的实体瘤。虽然基于顺铂化疗对TC患者非常有效,但化疗抗性的产生仍占疾病相关死亡的10%。因此,需要能够真实反映患者肿瘤的临床前模型来协助靶点发现和药物开发。

Laryngoscope:扩展随访期间顺铂相关的和年龄相关的听力损失关系研究

顺铂相关的听力损失(HL)在治疗后产生。最近,有研究人员在控制的纵向研究的扩展随访中调查了顺铂化疗(CBCT)睾丸癌幸存者(TCSs)中的HL情况。研究包括了82名CBCT治疗的TCSs患者,时间为1980年到1994年之间,且参与了2种调查,包括12年后纯音听觉测试(0.125-8kHz)和31年后自我报道的HL。听力阈值为基于普通对照且年龄匹配群体听力阈值年龄调整后的。听力损失定义为在任何频率

NCCN临床实践指南:睾丸癌(2019.V1)

2018年10月,美国国家综合癌症网络(NCCN)发布了睾丸癌指南2019年第1版,指南主要内容涉及: 指南更新摘要 检查,初级治疗和病理诊断 单纯精原细胞癌诊断后检查和临床分期 非精原细胞癌诊断后检查和临床分期 复发和二线治疗 精原细胞癌的随访 非精原细胞瘤的随访 单纯睾丸精原细胞癌放射治疗原则 进展期疾病风险分层 生殖细胞肿瘤初始化疗方案 转移性生殖细胞瘤二线化疗方案 转移性生殖细胞瘤后续性化

Br J Cancer:顺铂治疗加速睾丸癌幸存者的血管老化

睾丸癌(TC)虽然仅占男性所有癌症的1%,却是影响15至35岁男性的最常见的实体瘤。根据疾病的分期,一般采取睾丸切除术或切除术结合放疗(RT)、铂类药物化疗(CT)的方式进行治疗。至顺铂(cispla

NCCN临床实践指南:睾丸癌(2020.V1)

2019年10月,美国国家综合癌症网络(NCCN)发布了睾丸癌指南2020年第1版,指南主要内容涉及: 指南更新摘要 检查,初级治疗和病理诊断 单纯精原细胞癌诊断后检查和临床分期 非精原细胞癌诊断后检查和临床分期 复发和二线治疗 精原细胞癌的随访 非精原细胞瘤的随访 单纯睾丸精原细胞癌放射治疗原则 进展期疾病风险分层 生殖细胞肿瘤初始化疗方案 转移性生殖细胞瘤二线化疗方案 转移性生殖细胞瘤后续性化

拓展阅读

IVD前沿丨无标记成像技术可用于癌症初筛

研究开发PANORAMA技术检测sEV,用于癌症检测,包括sEV计数、大小测定、货物分析等,能区分癌症患者与健康个体,有望用于癌症筛查。

读书报告 | HUDSON研究:基于生物标志物选择的靶向治疗联合度伐利尤单抗治疗晚期NSCLC的饿期伞试验

HUDSON临床试验显示了durvalumab–ceralasertib组在多线治疗后进展的NSCLC中的显著疗效,与其他方案相比,反应率和疾病控制率明显更高,PFS和OS明显更长。

论文解读|Yuping Zhang/Shunqing Wang教授团队揭示T细胞受体谱分析在SAA患者免疫抑制疗法中的预测价值

该研究探讨了T细胞受体(TCR)谱系与免疫抑制疗法(IST)在SAA患者疗效之间的潜在关联,为治疗策略的优化提供了新见解。

​【Blood Rev】复发难治套细胞淋巴瘤的治疗流程图

BTK抑制剂改变R/R套细胞淋巴瘤治疗,文中提出二线治疗流程图,介绍多种治疗策略及移植作用,未来需研究最佳排序和相关生物标志物。

未来的早期癌症检测方法:合成生物标志物

癌症也可以通过成像系统进行检测,这些系统可能具有合成生物标记物方法的基本特征,例如报告基因成像。这些新兴的技术推动了早期癌症检测的发展,合成生物标志物可能成为未来的早期癌症检测方法。

IVD前沿丨帕金森病(PD)早期诊断新型生物标志物

这些结果强调了血浆中含有miR-44438的EV作为α-突触核蛋白病早期检测和进展监测的生物标志物的潜力。